| Description | Tau tracer 1 is a radiopharmaceutical agent designed specifically for visualizing Tau protein aggregates, commonly associated with neurodegenerative diseases. Its primary application lies in the diagnosis of these conditions. |
| In vitro | Tau tracer 1 (compound 13) can be employed in the selective Tau detection of disorders and abnormalities associated with Tau aggregates such as Alzheimer's disease and other tauopathies using Positron Emission Tomography (PET) Imaging[1]. |
| molecular weight | 533.591 |
| Molecular formula | C34H23N5O2 |
| CAS | 2173353-53-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Heiko Kroth, et al. Compounds for imaging tau protein aggregates. WO2018015549A1. |